{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:10:32Z","timestamp":1793070632663,"version":"4.5.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE023783-01A."],"award-info":[{"award-number":["R01DE023783-01A."]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event in patients treated with antiresorptives. Management of MRONJ is challenging, and no non-antibiotic, established medical treatment exists. Intermittent parathyroid hormone (iPTH) has been used off-label to treat MRONJ with favorable results. However, its medical efficacy has rarely been substantiated in clinical or preclinical experiments. Using a validated rice rat, infection-based model of MRONJ, we evaluated the effects of iPTH on established MRONJ. We hypothesize that iPTH contributes to MRONJ resolution by enhancing alveolar bone turnover and healing oral soft tissues. Eighty-four rice rats began a standard rodent chow diet at age 4 weeks to induce localized periodontitis. Rats were simultaneously randomized to receive saline (vehicle, VEH) or zoledronic acid (ZOL, 80\u2009\u03bcg\/kg IV) every 4 weeks. Oral exams were conducted bi-weekly to assign a gross quadrant grade (GQG, 0\u20134) to evaluate any lesion at the lingual aspect of the interdental space between maxillary molar (M2) and M3. 14 of 20 VEH-treated rice rats (70%) developed maxillary localized periodontitis with GQG 2\u20133 after 30\u2009\u00b1\u200910 weeks of saline. Additionally, 40 of 64 ZOL-treated rice rats with periodontitis developed MRONJ-like lesions after 30\u2009\u00b1\u200910 weeks of ZOL treatment. Rice rats with localized periodontitis or MRONJ-like lesions were treated with saline or iPTH (40\u2009\u03bcg\/kg) subcutaneously (SC) 3 times\/week For 6 weeks until euthanasia. We found that iPTH -treated ZOL rats had a lower prevalence of MRONJ (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001), with lower severity extent of oral lesions (<jats:italic>p<\/jats:italic> =\u20090.003) and percentage of empty osteocyte lacunae (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001). ZOL rats treated with iPTH displayed a higher osteoblast surface (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001), more osteoblasts (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001), higher osteoclast surface (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001) and more osteoclasts (<jats:italic>p<\/jats:italic> =\u20090.002) at alveolar bone surfaces than ZOL\/VEH rats. Greater gingival epithelial thickness and epithelial cell proliferation rate was found in the oral mucosa and gingiva of ZOL\/PTH rats than in ZOL\/VEH rats (<jats:italic>p<\/jats:italic> &amp;lt;\u20090.001). Our data suggest that iPTH is an efficacious non-operative medicinal therapy that accelerates oral healing and enhances the resolution of MRONJ lesions in ZOL-treated rice rats.<\/jats:p>","DOI":"10.3389\/fmed.2023.1179350","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T06:13:26Z","timestamp":1687155206000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats"],"prefix":"10.3389","volume":"10","author":[{"given":"E. J.","family":"Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Jiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Freehill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Yarrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. B.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ignacio","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the Jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International task force on osteonecrosis of the, diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/dj4040032","article-title":"Prevalence of medication-related osteonecrosis of the jaw in patients with breast Cancer, prostate Cancer, and multiple myeloma","volume":"4","author":"Rugani","year":"2016","journal-title":"Dent J (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jbo.2018.09.008","article-title":"Benefits and risks of adjuvant treatment with zoledronic acid in stage II\/III breast cancer","volume":"13","author":"Coleman","year":"2018","journal-title":"J Bone Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00520-010-1061-0","article-title":"RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?","volume":"19","author":"Van den Wyngaert","year":"2011","journal-title":"Support Care Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1200\/JCO.2017.75.4614","article-title":"Role of bone-modifying agents in metastatic breast Cancer: an American Society of Clinical Oncology-Cancer Care Ontario focused guideline update","volume":"35","author":"Van Poznak","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jbmr.4049","article-title":"Osteoporosis Management in the era of COVID-19","volume":"35","author":"Yu","year":"2020","journal-title":"J Bone Miner Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia","year":"2016","journal-title":"Bone"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.joen.2016.07.020","article-title":"Preexisting periapical inflammatory condition exacerbates tooth extraction-induced bisphosphonate-related osteonecrosis of the jaw lesions in mice","volume":"42","author":"Song","year":"2016","journal-title":"J Endod"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J Dent Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","article-title":"Japanese study Group of co-operative Dentistry with, medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study","volume":"30","author":"Hasegawa","year":"2019","journal-title":"Osteoporos Int"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/jbmr.1669","article-title":"Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis","volume":"27","author":"Aguirre","year":"2012","journal-title":"J Bone Miner Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","article-title":"Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model","volume":"68","author":"de Molon","year":"2014","journal-title":"Bone"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/odi.13052","article-title":"Zoledronate treatment duration is linked to bisphosphonate-related ONJ prevalence in Rice rats with generalized periodontitis","volume":"25","author":"Messer","year":"2019","journal-title":"Oral Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bone.2017.12.025","article-title":"Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis","volume":"108","author":"Messer","year":"2018","journal-title":"Bone"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00520-010-0882-1","article-title":"A systematic review of bisphosphonate osteonecrosis (BON) in cancer","volume":"18","author":"Migliorati","year":"2010","journal-title":"Support Care Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws--a review","volume":"48","author":"Kuhl","year":"2012","journal-title":"Oral Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.coms.2012.10.002","article-title":"Emerging concepts in the management and treatment of osteonecrosis of the jaw","volume":"25","author":"Ruggiero","year":"2013","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/pho.2007.2181","article-title":"Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases","volume":"26","author":"Vescovi","year":"2008","journal-title":"Photomed Laser Surg"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","article-title":"Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases","volume":"33","author":"Lee","year":"2007","journal-title":"J Oral Implantol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hed.20864","article-title":"Treatment results of bisphosphonate-related osteonecrosis of the jaws","volume":"30","author":"Wutzl","year":"2008","journal-title":"Head Neck"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3899\/jrheum.081176","article-title":"Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy","volume":"36","author":"Lau","year":"2009","journal-title":"J Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","article-title":"Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study","volume":"47","author":"Ristow","year":"2019","journal-title":"J Craniomaxillofac Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.4317\/medoral.22013","article-title":"The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw","volume":"22","author":"Eguchi","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/odi.13046","article-title":"Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: case\u2013control study","volume":"25","author":"McGowan","year":"2019","journal-title":"Oral Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int. J. Implant Dent."},{"key":"ref40","first-page":"18","article-title":"The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics","volume":"34","author":"Lombardi","year":"2011","journal-title":"J Endocrinol Investig"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3275\/7925","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J Endocrinol Investig"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled, randomized trial","volume":"38","author":"Sim","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","article-title":"Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos Int"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00198-013-2570-8","article-title":"Early effects of parathyroid hormone on bisphosphonate\/steroid-associated compromised osseous wound healing","volume":"25","author":"Kuroshima","year":"2014","journal-title":"Osteoporos Int"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41598-020-79787-w","article-title":"Effects of pre-extraction intermittent PTH administration on extraction socket healing in bisphosphonate administered ovariectomized rats","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.joms.2015.07.005","article-title":"Histopathological effects of Teriparatide in medication-related osteonecrosis of the jaw: an animal study","volume":"74","author":"Keskinruzgar","year":"2016","journal-title":"J Oral Maxillofac Surg"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.ijom.2013.05.001","article-title":"The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study","volume":"42","author":"Dayisoylu","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jcms.2021.02.023","article-title":"Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model","volume":"49","author":"Jung","year":"2021","journal-title":"J Craniomaxillofac Surg"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcms.2016.12.010","article-title":"Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats","volume":"45","author":"Zandi","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jcms.2017.12.027","article-title":"Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats","volume":"46","author":"Zandi","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/JPER.19-0620","article-title":"Management of medication-related osteonecrosis of jaw: comparison between icariin and teriparatide in a rat model","volume":"92","author":"Liu","year":"2021","journal-title":"J Periodontol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/dj4040036","article-title":"Impact of soft tissue pathophysiology in the development and maintenance of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"4","author":"Ziebart","year":"2016","journal-title":"Dent J (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br J Haematol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"104932","DOI":"10.1016\/j.archoralbio.2020.104932","article-title":"Influence of parathyroid hormone on periodontal healing in animal models: a systematic review","volume":"120","author":"Stutz","year":"2020","journal-title":"Arch Oral Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12964-020-00541-w","article-title":"PTH derivative promotes wound healing via synergistic multicellular stimulating and exosomal activities","volume":"18","author":"Shen","year":"2020","journal-title":"Cell Commun Signal"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e2107363118","DOI":"10.1073\/pnas.2107363118","article-title":"Activation of PTH1R alleviates epididymitis and orchitis through Gq and beta-arrestin-1 pathways","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/milmed\/usz252","article-title":"The effects of continual intermittent parathyroid hormone treatment on human periodontal ligament fibroblasts in an in vitro wound repopulation model","volume":"185","author":"Gilbert","year":"2020","journal-title":"Mil Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.beem.2008.08.002","article-title":"Vitamin D and breast cancer risk","volume":"22","author":"Colston","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1359\/jbmr.2000.15.11.2129","article-title":"Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells","volume":"15","author":"Cataisson","year":"2000","journal-title":"J Bone Miner Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"L194","DOI":"10.1152\/ajplung.2000.279.1.L194","article-title":"Parathyroid hormone-related protein reduces alveolar epithelial cell proliferation during lung injury in rats","volume":"279","author":"Hastings","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.3892\/mmr.2018.8567","article-title":"Effects of recombinant human parathyroid hormone (1-34)on cell proliferation, chemokine expression and the hedgehog pathway in keratinocytes","volume":"17","author":"Bu","year":"2018","journal-title":"Mol Med Rep"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"13623","DOI":"10.1016\/S0021-9258(18)42258-2","article-title":"Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide","volume":"267","author":"Kaiser","year":"1992","journal-title":"J Biol Chem"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/01.RES.0000248184.21644.20","article-title":"Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP\/p27kip1 pathway","volume":"99","author":"Fiaschi-Taesch","year":"2006","journal-title":"Circ Res"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0169-6009(92)90879-I","article-title":"PTH stimulates the proliferation of TE-85 human osteosarcoma cells by a mechanism not involving either increased cAMP or increased secretion of IGF-I, IGF-II or TGF beta","volume":"16","author":"Finkelman","year":"1992","journal-title":"Bone Miner"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1359\/jbmr.1997.12.10.1596","article-title":"The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors","volume":"12","author":"Onishi","year":"1997","journal-title":"J Bone Miner Res"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/154405910308201006","article-title":"Parathyroid hormone protects against periodontitis-associated bone loss","volume":"82","author":"Barros","year":"2003","journal-title":"J Dent Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.joen.2014.12.008","article-title":"Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice","volume":"41","author":"Otawa","year":"2015","journal-title":"J Endod"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.archoralbio.2017.06.033","article-title":"Intermittent administration of parathyroid hormone ameliorated alveolar bone loss in experimental periodontitis in streptozotocin-induced diabetic rats","volume":"83","author":"Chen","year":"2017","journal-title":"Arch Oral Biol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.archoralbio.2017.06.013","article-title":"Parathyroid hormone-related peptide (1-34) reduces alveolar bone loss in type 1 diabetic rats","volume":"83","author":"Zhang","year":"2017","journal-title":"Arch Oral Biol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"115866","DOI":"10.1016\/j.bone.2021.115866","article-title":"Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in Rice rats (Oryzomys palustris)","volume":"145","author":"Castillo","year":"2021","journal-title":"Bone"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"116184","DOI":"10.1016\/j.bone.2021.116184","article-title":"Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"key":"ref76","first-page":"51","article-title":"Breeding, husbandry, veterinary care, and hematology of marsh Rice rats (Oryzomys palustris), a small animal model for periodontitis","volume":"54","author":"Aguirre","year":"2015","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref77","first-page":"43","article-title":"Prevalence of food impaction-induced periodontitis in conventionally housed marsh Rice rats (Oryzomys palustris)","volume":"67","author":"Messer","year":"2017","journal-title":"Comp Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"115141","DOI":"10.1016\/j.bone.2019.115141","article-title":"Anti-vascular endothelial growth factor antibody monotherapy causes destructive advanced periodontitis in rice rats (Oryzomys palustris)","volume":"130","author":"Messer","year":"2020","journal-title":"Bone"},{"key":"ref79","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Cullere","year":"1999","journal-title":"Lab Anim Sci"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J Bone Miner Res"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1359\/jbmr.070313","article-title":"Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats","volume":"22","author":"Aguirre","year":"2007","journal-title":"J Bone Miner Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1089\/neu.2013.3155","article-title":"Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury","volume":"31","author":"Yarrow","year":"2014","journal-title":"J Neurotrauma"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomogrraphy","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings","volume":"118","author":"Franco-Pretto","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jot.2018.01.003","article-title":"Steroid-associated osteonecrosis animal model in rats","volume":"13","author":"Zheng","year":"2018","journal-title":"J Orthop Translat"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jor.20733","article-title":"A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday","volume":"27","author":"Yang","year":"2009","journal-title":"J Orthop Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","article-title":"Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice","volume":"56","author":"Kuroshima","year":"2013","journal-title":"Bone"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1158\/1078-0432.CCR-10-1614","article-title":"Effect of zoledronate on oral wound healing in rats","volume":"17","author":"Yamashita","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0002-9440(10)63963-6","article-title":"Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity","volume":"158","author":"Aguirre","year":"2001","journal-title":"Am J Pathol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jbmr.2396","article-title":"Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss","volume":"30","author":"Beggs","year":"2015","journal-title":"J Bone Miner Res"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"20130144","DOI":"10.1259\/dmfr.20130144","article-title":"Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model","volume":"43","author":"Ersan","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/odi.13275","article-title":"The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice","volume":"26","author":"Yu","year":"2020","journal-title":"Oral Dis"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijom.2013.06.016","article-title":"Zoledronic acid impairs re-epithelialization through down-regulation of integrin alphavbeta6 and transforming growth factor beta signalling in a three-dimensional in vitro wound healing model","volume":"43","author":"Saito","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","article-title":"The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study","volume":"16","author":"Pabst","year":"2012","journal-title":"Clin Oral Investig"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0022034511407918","article-title":"Bisphosphonates inhibit expression of p63 by oral keratinocytes","volume":"90","author":"Scheller","year":"2011","journal-title":"J Dent Res"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.archoralbio.2011.11.015","article-title":"Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes","volume":"57","author":"Ohnuki","year":"2011","journal-title":"Arch Oral Biol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/bjc.2011.403","article-title":"Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma","volume":"105","author":"Colley","year":"2011","journal-title":"Br J Cancer"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1073\/pnas.1109036109","article-title":"Anabolic action of parathyroid hormone regulated by the beta2-adrenergic receptor","volume":"109","author":"Hanyu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"15300","DOI":"10.1038\/s41598-017-15563-7","article-title":"Catabolic effects of human PTH (1-34) on bone: requirement of monocyte chemoattractant Protein-1 in murine model of hyperparathyroidism","volume":"7","author":"Siddiqui","year":"2017","journal-title":"Sci Rep"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1600-0765.2006.00899.x","article-title":"Parathyroid hormone modifies human periodontal ligament cell proliferation and survival in vitro","volume":"41","author":"Lossd\u00f6rfer","year":"2006","journal-title":"J Periodontal Res"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"606043","DOI":"10.3389\/fimmu.2021.606043","article-title":"The role of the immune response in the development of medication-related osteonecrosis of the jaw","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3899\/jrheum.091022","article-title":"More on the resolution of bisphosphonate-associated osteonecrosis of the jaw","volume":"37","author":"Tsai","year":"2010","journal-title":"J Rheumatol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1359\/JBMR.051023","article-title":"Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis","volume":"21","author":"Tashjian","year":"2006","journal-title":"J Bone Miner Res"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"888208","DOI":"10.3389\/fphar.2022.888208","article-title":"Efficacy of the combination of Teriparatide and Denosumab in the treatment of postmenopausal osteoporosis: a meta-analysis","volume":"13","author":"Sun","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"607017","DOI":"10.3389\/fphar.2020.607017","article-title":"Combination therapy of PTH and Antiresorptive drugs on osteoporosis: a review of treatment alternatives","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/14656566.2020.1717468","article-title":"Combination and sequential treatment in women with postmenopausal osteoporosis","volume":"21","author":"Anastasilakis","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S2213-8587(19)30255-4","article-title":"Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial","volume":"7","author":"Tsai","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1179350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T06:13:35Z","timestamp":1687155215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1179350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":111,"alternative-id":["10.3389\/fmed.2023.1179350"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1179350","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"article-number":"1179350"}}